[Asia Economy Reporter Minji Lee] Prostemics announced on the 11th that it has obtained a domestic patent for oligonucleotides and pharmaceutical compositions for cancer prevention and treatment containing them.
The company explained, "Since it targets stemness genes of cancer stem cells, it will be applied to precision medicine technologies including companion diagnostics in the future."
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
